Pathways to ensure universal and affordable access to hepatitis C treatment

Pathways to ensure universal and affordable access to hepatitis C treatment

Abstract Direct-acting antivirals (DAAs) have dramatically changed the landscape of hepatitis C treatment and prevention. The World Health Organization has called for the elimination of hepatitis C as a public health threat by 2030. However, the discrepancy in DAA prices across low-, middle- and hig...

Full description

Bibliographic Details
Main Authors: Caitlin H. Douglass, Alisa Pedrana, Jeffrey V. Lazarus, Ellen F. M. ‘t Hoen, Radi Hammad, Ricardo Baptista Leite, Andrew Hill, Margaret Hellard
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Medicine
Subjects:
Healthcare financing
Hepatitis C
Treatment
Online Access:http://link.springer.com/article/10.1186/s12916-018-1162-z

Internet

http://link.springer.com/article/10.1186/s12916-018-1162-z

Similar Items